# Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients

> **NCT07162779** · NA · ENROLLING_BY_INVITATION · sponsor: **Affiliated Hospital of Jiangnan University** · enrollment: 5 (estimated)

## Conditions studied

- PET CT

## Interventions

- **DRUG:** Radioactive drugs are administered through intravenous injection.

## Key facts

- **NCT ID:** NCT07162779
- **Lead sponsor:** Affiliated Hospital of Jiangnan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-10-29
- **Primary completion:** 2026-12-16
- **Final completion:** 2026-12-16
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162779, "Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07162779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*